Abstract: A freeze protection method for a fuel cell system is disclosed. The fuel cell system includes an evaporative cooler device equipped for cooling a heat exchanger of a fuel cell device of the fuel cell system having a feed line, through which during the operation of the fuel cell system, water is pumped to a sprinkling device of the evaporative cooler device and by way of the sprinkling device, the water is applied onto the heat exchanger equipped for temperature-controlling a fuel cell stack of the fuel cell device. The method includes blowing out the evaporative cooler device as part of a deactivation method of the fuel cell system.

Abstract: The invention relates to a method for sprinkling a heat exchanger of a fuel cell vehicle with a fluid. The heat exchanger comprises a sprinkling surface and at least one group with at least one part surface. All part surfaces of all groups together fully represent the sprinkling surface. In the method, all part surfaces of the group are sprinkled with the fluid within a sprinkling period and not sprinkled within a drying period. The invention also relates to a sprinkling system for carrying out the method.

Abstract: A fuel cell device of a motor vehicle is disclosed. The fuel cell device includes a fuel cell, a supply air path leading to the fuel cell for a cathode supply air flow, and an exhaust air path leading away from the fuel cell for a cathode exhaust air flow. The supply air path and the exhaust air path are routed through a humidifier that humidifies the supply air and dehumidifies the exhaust air. The exhaust air path is further routed through a water separator that removes water from the exhaust air to provide evaporation water. A heat exchanger for cooling the fuel cell is provided that has an evaporative cooler for cooling the heat exchanger. The evaporative cooler is assigned to the water separator in fluidic communication and is supplied with evaporation water by the water separator.

Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.

Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.

Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.

Abstract: Described are methods and compositions for clinically proven safe and effective treatment of ulcerative colitis according to the product label described herein, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.

Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.

Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.

Abstract: A flyer bow for wire bunching or wire stranding machines has an inner flank on which is introduced longitudinally and centrally a tube which is formed of a wear-resistant material and which acts as an integrated wire guide. This results in the flyer bow having a compact construction, uniform wire guidance and an easy exchangeability of the parts subjected to wear due to the friction of the wires.

Abstract: A flyer bow for wire bunching or wire stranding machines has an inner flank on which is introduced longitudinally and centrally a tube which is formed of a wear-resistant material and which acts as an integrated wire guide. This results in the flyer bow having a compact construction, uniform wire guidance and an easy exchangeability of the parts subjected to wear due to the friction of the wires.

Abstract: Pharmaceutical preparations are provided for directly treating a skin growth, such as a wart, or as drying agents for pre and post surgical removal of the skin growth or for non-surgical laser treatment of the skin growth where dryness is required. In one exemplary embodiment, the composition includes formaldehyde as an active ingredient, wherein the formaldehyde is present in an amount from about 2% to about 20% by weight and it includes at least one non-active ingredient and wherein the composition is in the form of a gel or a powder.

Abstract: A method of applying a medicament using a disposable swab applicator formed of a swab and a housing including a reservoir member and an adjustable sleeve member is provided. The reservoir member has a channel formed therein for receiving and storing the medicament with the adjustable inner sleeve member also being disposed within the channel. The inner sleeve member has an open first end which receives the swab and a closed second end with one or more windows formed between the first and second ends. In a first position within the reservoir member, the closed second end of the inner sleeve member forms a seal with the reservoir member to effectively store the medicament in the reservoir member. Movement of the inner sleeve member from the first position to a second position causes the medicament to flow through the one or more windows into contact with the swab resulting in the swab being ready for use.

Abstract: A method of applying a medicament using a disposable swab applicator formed of a swab and a housing including a reservoir member and an adjustable sleeve member is provided. The reservoir member has a channel formed therein for receiving and storing the medicament with the adjustable inner sleeve member also being disposed within the channel. The inner sleeve member has an open first end which receives the swab and a closed second end with one or more windows formed between the first and second ends. In a first position within the reservoir member, the closed second end of the inner sleeve member forms a seal with the reservoir member to effectively store the medicament in the reservoir member. Movement of the inner sleeve member from the first position to a second position causes the medicament to flow through the one or more windows into contact with the swab resulting in the swab being ready for use.

Abstract: Disclosed is a composition comprising a water based nail lacquer and urea, which is useful in the partial or complete evulsion of the nails, and in the treatment of fungal, yeast and bacterial infections of the nails and the nail beds. Also disclosed are methods for evulsing nails, and for treating antifungal and antibacterial infections, comprising the administration of the composition of the invention to the toenails or fingernails of a mammal.

Abstract: Mineral fibers are provided with a phosphorus-containing coating to impart high-temperature resistance without substantially affecting mechanical performance. Preferred mineral-fiber compositions according to the invention with relatively high levels of SiO.sub.2 and low levels of Al.sub.2 O.sub.3 and Fe.sub.2 O.sub.3 compositions may advantageously be used for insulation. Such compositions have high-temperature resistance and high biosolubility, yet have properties which allow current processes to fabricate them into insulation. Preferably, the mineral fibers have a KI value.gtoreq.40.

Abstract: A database management system of the present invention includes a computer having a memory and a processor, a database for storing information in the memory as field values in a record, an indexing component for referencing a plurality of records by a value of the field(s), an input device for selecting desired records by entering a range of values corresponding to the field(s) (indexed on), and a component for accessing the desired records as an order set, where only records having a value within said range are included within the set. System and methods are also described for optimizing the access of information from the database management system.

Abstract: A stable solvent system for imidazole derivatives useful in treating antifungal diseases is described. The system comprises a primary carboxylic acid, a polar solvent, a solubilizer, one or more surfactants, and therapeutically effective amounts of an imidazole derivative, preferably miconazole nitrate.

Abstract: A method and materials for separating oil from water, using stacked disks to coalesce the oil, is disclosed. The method of coalescence allows configuration of systems which are compact, efficient, adaptable to modular configuration, and have a very high flow rate.